Immunomic Therapeutics

Immunomic Therapeutics

Immunomic Therapeutics

Bill is CEO of Immunomic Therapeutics, a biotech company pioneering next generation vaccines that will transform lives.
Type
B2c
Founded
2005
Raised
$65.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$61,300,000
Corporate round - 2020
HLB Co
$1,028,999
Venture capital - 2014
Team Size
1–10
Employees
$61,300,000 Corporate round
FinSMEs

Immunomic Therapeutics Closes $61.3M Financing

Technical.ly

Immunomic Therapeutics is launching an incubator and looking for one lucky startup Baltimore

Funding Education